Navigation Links
Folic acid lowers blood arsenic levels in Bangladesh
Date:10/10/2007

A new study conducted in Bangladesh finds that folic acid supplements can dramatically lower blood arsenic levels in individuals chronically exposed to arsenic-contaminated drinking water. Arsenic is a toxic element that is naturally present in some soils and water. Arsenic-contaminated drinking water is currently a significant public health problem in at least 70 countries, including several developing countries and also parts of the United States. Chronic arsenic exposure is associated with increased risk for skin, liver and bladder cancers, skin lesions, cardiovascular disease, and other adverse health outcomes. The study was funded by the National Institute of Environmental Health Sciences (NIEHS) at the National Institutes of Health (NIH).

Researchers found that treatment with 400 micrograms a day of folic acid, the U.S. Recommended Dietary Allowance, reduced total blood arsenic levels in a Bangladesh study population by 14 percent. Folate is a B vitamin found in leafy vegetables, citrus fruits, beans, and whole grains. Folic acid can also be taken as a vitamin supplement, and in the United States, it is added to flour and other fortified foods. The researchers found that folate deficiency is very common in Bangladesh, where the study was conducted, but is not as problematic in the United States due to folate fortification. Additional studies are needed to determine if folic acid similarly lowers blood arsenic in populations where folate deficiency is less common, such as in the United States.

William Suk, Ph.D., Acting Deputy Director of the NIEHS discussed the significance of this work in Bangladesh to the U.S. He explains that arsenic contamination of groundwater is one of the five most common inorganic compounds found at Superfund sites and is present at over 70 percent of the sites. Because of the prevalence of arsenic, the SBRP has placed an emphasis on supporting arsenic-related research in heavily affected areas all over t
'/>"/>

Contact: Robin Mackar
rmackar@niehs.nih.gov
919-541-0073
NIH/National Institute of Environmental Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Medical whistleblowers speak out
2. Bumblebees copy one another when contending with unfamiliar flowers
3. FDA: Highly Unlikely Green Tea Lowers Cancer Risk
4. Reducing antibiotic use lowers rates of drug-resistant bacteria
5. Recreating Flowers for Algernon with a happy ending
6. AIDS drug from sunflowers
7. How nice, brown rice: Study shows rice bran lowers blood pressure in rats
8. Wild bees and the flowers they pollinate are disappearing together
9. Genetic snooze button governs timing of spring flowers
10. Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds
11. How did bilaterally symmetric flowers evolve from radially symmetric ones?

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ewswire-FirstCall/ -- Quest Diagnostics Incorporat...diagnostic testing, information and services, anno...0, 2009, income from continuing operations rose to...60 million, or $0.81 per diluted share, for the th...s were reduced by a $0.03 per share charge associa...
(Date:11/4/2009)...PRNewswire/ -- GenVault Corporation, the leader in...mic discovery, medicine and identification, today ...sident and CEO, will be presenting at the BIOCOM I...d 27th in La Jolla, CA. ,, During the presentat...mpany together with recent customer, technical and...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 1SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 1Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 2
...y (ASH TM ) and American Board of Internal Medicin...a new wave of performance evaluation tools for blo...uirements to maintain ABIM certification, ASH and ...rovement Module (PIM), a web-based tool physicians...ment requirement for recertification. Participants...
...is the deadliest form of the disease, with fewer t...ear prognosis for survival. To find out what drive...d to rapidly screen for drugs that might stop IBC... Diego (UCSD), have come up with an unlikely yet ...ble for xenografts. , More properly, it’s a trans...
...s are heading a worldwide research project which c...diarrhoea in children in developing countries. , T... being piloted in four hospitals in India, will of...ms of the disease quickly, cheaply and with little...ications for improving children,s health could be ...
Other Biology News:New tool helps blood specialists improve patient care 2A fisheye view of the deadliest breast cancer 2Hope for major advance in fighting world killer disease 2Hope for major advance in fighting world killer disease 3
(Date:11/5/2009)...YNBROOK, N.Y., Nov. 5 Bi...biopharmaceutical company developing first-in-clas...financial results for the third quarter ended Sept...at, in September of this year, the FDA,s Arthritis...vote of 12-0, the approval of XIAFLEX(TM) for the ...
(Date:11/5/2009)...AN DIEGO, CA, November 5, 2009 /PRNewswire-FirstCa...ocused on using proprietary taste receptor-based t...or the food, beverage, and ingredient supply indus...ted financial results for the third quarter ended ...r the third quarter of 2009, compared to $4.0 mill...
(Date:11/5/2009)... PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-...JGP ) ("BMP Sunstone" or the "Company") today anno...ter 2009 financial results on,Monday, November 9, ...any will hold a conference call at 5:00 pm ET on N...lts. Listeners may access the call by,dialing 1-8...
(Date:11/5/2009)... Brooke Sanders brings a new loo...CA (PRWEB) November 5, 2009 -- Professional Reprog...rographics company is pleased to present Brooke Sa...their graphics/PR specialist. The addition of Broo...ent growth within Professional Reprographics., , ,...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...elixis,Inc. (Nasdaq: EXEL ) announced earlier tod...ommitment from Deerfield Management. The arrangeme...ive conference call at 5:00 a.m.,PT/8:00 a.m. ET t...the,discussion, visit the Event Calendar page unde...ay of the conference call will be available until ...
...ne Control, Trait Stacking in ...MOND, Calif., June 5 Dow,AgroSciences LLC and San...today the successful completion of research milest...l License Agreement. These milestones represent,th...DNA-binding protein,(ZFP) technology to the genera...
...C Santa Barbara,s Solid-State Lighting and Energy ...nce of Asturias Award for Technical and Scientific... is presented with a medal and a Joan Miro sculptu...ecipients in each category also share a 50,000 (US...esearch prize is given annually to "the individual...
Other Biology Technology:Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 3Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 4Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 5
Mouse Anti-Human TNPO2 Polyclonal Antibody, Unconjugated from Novus Biologicals
... ChIP Grade HDAC4 is a member of the class II mam...4 amino acid residues. Its C-terminal sequence is ...HDA1. HDAC4, unlike other deacetylases, shuttles b...lving active nuclear export. Association of HDAC4 ...
FluoroGuard Antifade Reagent from Bio-Rad
Mouse Anti-Human PDK2 Monoclonal Antibody, Unconjugated, Clone 2G1 from Novus Biologicals
Biology Products: